Cargando…
The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma
BACKGROUND: To evaluate the promoter methylation status of MUC2 gene and mRNA expression in patients with hepatocellular carcinoma. METHODS: We analyzed MUC2 methylation by MSP, and MUC2 mRNA by real-time PCR in 74 HCC. RESULTS: MUC2 mRNA were lower in HCC tissues (Mean (-ΔCt) = −4.70) than that in...
Autores principales: | Ling, Yang, Zhu, Jing, Gao, Lu, Liu, Yongping, Zhu, Changtai, Li, Rong, Wei, Lixin, Zhang, Changsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583682/ https://www.ncbi.nlm.nih.gov/pubmed/23347460 http://dx.doi.org/10.1186/1471-2350-14-14 |
Ejemplares similares
-
The Silencing of RECK Gene is Associated with Promoter Hypermethylation and Poor Survival in Hepatocellular Carcinoma
por: Zhang, Changsong, et al.
Publicado: (2012) -
Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma
por: Guo, Yulin, et al.
Publicado: (2017) -
METH-2 silencing and promoter hypermethylation in NSCLC
por: Dunn, J R, et al.
Publicado: (2004) -
Hypermethylation and Expression Silencing of PDCD4 Gene in Hepatocellular Carcinoma: A Consort Study
por: Ding, Xianglian, et al.
Publicado: (2016) -
The Clinical Value of Huangqi Injection in the Treatment of Leucopenia: A Meta-Analysis of Clinical Controlled Trials
por: Zhang, Changsong, et al.
Publicado: (2013)